Japan trials Israeli tumor treatment

(Thanks to Nevet – Broaderview.com) Japan has bought its first IceSense3 systems from Israel’s IceCure Medical. The systems are already approved in the USA and Europe. Now Kamada Medical Center will use two $50,000 IceSense3 systems to kill breast tumors by freezing them. www.al-monitor.com/pulse/business/2013/10/icecure-medical-japan-kameda-medical-center-cancer.html Apple buys Cue. 21-year-old Israeli entrepreneur Daniel Gross has just sold his personal assistant app Cue to Apple for a cool $40 million. Cue searches for keywords in a person’s Facebook, LinkedIn and Twitter accounts without having to sign in to any of them. Apple could use Cue to help compete with Google Now.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published.